Spots Global Cancer Trial Database for Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Continuous Endostar Infusion Combined With Radiotherapy in Patients With Brain Metastases
Official Title: Phase II Study of Continuous Endostar Infusion Combined With Radiotherapy for the Treatment of Patients With Brain Metastases
Study ID: NCT01410370
Conditions
Study Description
Brief Summary: The aim of this study is to evaluate the clinical efficacy and safety of continuous Endostar infusion combined with radiotherapy for treatment of brain metastases.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China
Contact Details
Name: Xiaodong Jiang, MD
Affiliation: The First People's Hospital of Lianyungang
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
